Vitamin K Market Forecast Report 2025: Revenue and Outlook by Industry Players
Category: #business  By Ronak Bora  Date: 2021-03-31
  • share
  • Twitter
  • Facebook
  • LinkedIn

Vitamin K Market Forecast Report 2025: Revenue and Outlook by Industry Players

Vitamin K Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.

With the increasing prevalence of cardiovascular diseases and shifting consumer preferences towards healthy and nutritional diet, vitamin K market share has expanded substantially in the past few years. Vitamin K is one of the leading ingredients to help maintain body vitals and is being incorporated into healthcare products owing to beneficial effects on bone, cardiovascular health, preventing excessive bleeding, and healing wounds.

Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/1481

According to U.S. DA Human Nutrition Research Center on Aging, the deficiency of vitamin K can lead to low bone mass density and a rise in hip fractures in women. Described below are some prominent factors driving vitamin K industry outlook over the coming years:

Vitamin k has become one of the popular choices for dermal applications, such as skin and beauty treatments, as it helps in maintaining elasticity of the skin and reduces collagen in the body, making the skin appear smoother and more youthful. Pharmaceutical companies are substantially making usage of the ingredient in many different topical creams which aid in treating a variety of skin conditions. These are also widely adopted by patients who have undergone surgery, to help reduce bruising and swelling.

Eczema is a chronic disorder, which can make the life of a patient challenging and is a prime target for providers of topical treatment containing vitamin K. Estimates show that eczema is a dermal issue affecting around 35 million Americans each year.

Vitamin-K is now easily incorporated into cosmetics products and providing good results and stability to the skin as it has antioxidant properties which are essential for the blood vessel health, immune system, and keep the skin clean and fresh. Driven by these remarkable benefits, vitamin K market size from topical administration was registered at about USD 49 million in valuation in 2018 and will grow considerably in the near future.

According to a research, osteoporosis is considered as a leading contributor to fractures globally and affects around 75 million people in Japan, Europe, and the US. It is a known fact that vitamin-k is an important component for bone formation and needed for bone mineralization as well as maintaining calcium balance in the body.

Among the various sources of Vitamin-k, MK-7 is known to be one of the most preferred forms of supplementation for osteoporosis and osteopenia treatments. High demand for vit-k, owing to wide application in crucial treatments and growing acceptance of nutritional food products among people, will certainly promote industry trends.

Numerous research initiatives have been undertaken to prove the benefits of vitamin K2 to counter bone disorders. For instance, vitamin K2 had exhibited significant improvement in osteoporosis in Japan when served in the form of a traditional dish or given as a high-dose oral prescription.

In terms of the regional landscape, Asia Pacific vitamin K market is expected to witness nearly 9% growth over 2019-2025, with increasing birth rates in developing nations being a vital factor driving the demand for healthcare services and pharmaceutical products. For example, vitamin K1 injectables are administered extensively to prevent serious bleeding disorder in babies.

Population in APAC is predicted to surpass 4.77 billion by 2025, which indicates a massive potential for pharmaceutical companies with regard to developing innovative treatment options for every kind of disease and fatal illnesses.

Vitamin K deficiency bleeding (VKDB) is a severe problem which is found in newborns that can cause bleeding into the brain and may lead to brain damage or sometimes even death. With increasing incidents of VKDB expected over the coming years, APAC vitamin K industry will witness increased consumption regionwide.

In Jan 2019, NattoPharma had announced that its patented MenaQ7 is the only Vitamin K2 as MK-7 clinically validated for cardiovascular health. Vitamin K2 as MK-7 is the first compound till date shown to impact on arterial calcification by its activation of MGP as well as gaining considerable attention from the medical community as a potential therapy. Similar developments in orally administered products is likely to expedite vitamin-k industry outlook.

Industry players are putting rigorous efforts into improving their ROI and broaden geographical presence through implementation of substantial expansion tactics such as conducting R&D programs, mergers and acquisition, and product differentiation. Pfizer had recently merged its generic business with Mylan to bring more profitable and innovative drugs into its portfolio. With this merger, the company expanded various treatment options to patients across the healthcare domain.

BASF DSM, Livealth Biopharma, Amphastar Pharmaceuticals, Country Life, NOW Foods, NattoPharma, Kappa Bioscience, and Pfizer are the key manufacturers of vitamin K-based medical products. Global Market Insights, Inc. has estimated that global vitamin K market will surpass a valuation of USD 1 billion by 2025. 

Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/vitamin-k-market

Partial Chapter of the Table of Content 

Chapter 4. Vitamin K Market, By Type

4.1. Key segment trends

4.2. Vitamin K1

4.2.1. Market size, by region, 2014-2025 (USD Million)

4.3. Vitamin K2

4.3.1. Market size, by region, 2014-2025 (USD Million)

Chapter 5. Vitamin K Market, By Application

5.1. Key segment trends

5.2. Osteoporosis

5.2.1. Market size, by region, 2014-2025 (USD Million)

5.3. Vitamin K-dependent clotting factors deficiency (VKCFD)

5.3.1. Market size, by region, 2014-2025 (USD Million)

5.4. Prothrombin deficiency

5.4.1. Market size, by region, 2014-2025 (USD Million)

5.5. Vitamin K Deficiency Bleeding (VKDB)

5.5.1. Market size, by region, 2014-2025 (USD Million)

5.6. Dermal applications

5.6.1. Market size, by region, 2014-2025 (USD Million)

5.7. Others

5.7.1. Market size, by region, 2014-2025 (USD Million)

About Author

Ronak Bora    

Ronak Bora

A graduate in Electronics Engineering, Ronak writes for Technology Magazine and carries a rich experience in digital marketing, exploring how the online world works from a technical and marketing perspective. His other areas of interest include reading, music, and spo...

Read More>>

More News By Ronak Bora

RF Components Market share 2021 - Industry Growth Analysis to 2027
RF Components Market share 2021 - Industry Growth Analysis to 2027
By Ronak Bora

A detailed analysis of the RF components market is entailed in this research report. The driving for...

Flexible Display Market Size 2021 - Industry Trends Report to 2027
Flexible Display Market Size 2021 - Industry Trends Report to 2027
By Ronak Bora

An inherent blend of vital market definitions, the flexible display market report comprises details ...

Digital BSS Market Size 2021 | Global Industry Statistics Analysis 2027
Digital BSS Market Size 2021 | Global Industry Statistics Analysis 2027
By Ronak Bora

A detailed synopsis of the digital BSS market has been presented in this research report. The synops...